首页> 外文期刊>Journal of managed care pharmacy : >Community pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions
【24h】

Community pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions

机译:90天维护药物处方的社区药房和邮购成本和利用率

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Pharmacy benefit management (PBM) companies promote mail order programs that typically dispense 90-day quantities of maintenance medications, marketing this feature as a key cost containment strategy to address plan sponsors' rising prescription drug expenditures. In recent years, community pharmacies have introduced 90-day programs that provide similar cost advantages, while allowing these prescriptions to be dispensed at the same pharmacies that patients frequent for 30-day quantities. Objective: To compare utilization rates and corresponding costs associated with obtaining 90-day prescriptions at community and mail order pharmacies for payers that offer equivalent benefits in different 90-day dispensing channels. Methods: We performed a retrospective, cross-sectional investigation using pharmacy claims and eligibility data from employer group clients of a large PBM between January 2008 and September 2010. We excluded the following client types: government, third-party administrators, schools, hospitals, 340B (federal drug pricing), employers in Puerto Rico, and miscellaneous clients for which the PBM provided billing services (e.g., the pharmacy's loyalty card program members). All employer groups in the sample offered 90-day community pharmacy and mail order dispensing and received benefits management services, such as formulary management and mail order pharmacy, from the PBM. We further limited the sample to employer groups that offered equivalent benefits for community pharmacy and mail order, defined as groups in which the mean and median copayments per claim for community and mail order pharmacy, by tier, differed by no more than 5%. Enrollees in the sample were required to have a minimum of 6 months of eligibility in each calendar year but were not required to have filled a prescription in any year. We evaluated pharmacy costs and utilization for a market basket of 14 frequently dispensed therapeutic classes of maintenance medications. The proportional share of claims for each therapeutic class in the mail order channel was used to weight the results for the community pharmacy channel. Using ordinary least squares regression models, we controlled for differences between channel users with respect to the following confounding factors: age, gender, presence or absence of each of the top 11 drug-inferred conditions (e.g., asthma/chronic obstructive pulmonary disease, cardiovascular disease), drug mix, and calendar year. We calculated estimated predicted means holding all covariates at their mean values. For both 90-day dispensing channels, we calculated number of 90-day claims per member per year (PMPY) and cost per pharmacy claim, with all claims counts adjusted to 30-day equivalents (i.e., number of 90-day claims × 3). Differences were compared using t-tests for statistical significance. Results: Of 355 PBM clients prior to exclusions, 72 unique employers covering 644,071 unique members (range of approximately 100 to more than 100,000 members per employer) were included in the analysis. On an unadjusted basis, community pharmacies represented 80.8% of 90-day market basket claims (in 30-day equivalents: 3.97 claims PMPY vs. 0.95 in mailorder) and 77.2% of total allowed charges. After adjustments for therapeutic group mix and patient characteristics, predicted mean pharmacy claim counts PMPY were 4.09 for community pharmacy compared with 0.85 for mail order (P < 0.001). Predicted mean allowed charges per claim for community and mail order pharmacies did not significantly differ ($49.03 vs. $50.04, respectively, P = 0.202). Conclusions: When offered maintenance medications through community and mail order pharmacies on a benefit-equivalent basis, commercially insured employees and their dependents utilized the community pharmacy channel more frequently by a margin of more than 4 to 1 in terms of claims PMPY. Overall allowed charges per claim for community and mail order pharmacy did not significantly differ
机译:背景:药房收益管理(PBM)公司推行的邮购计划通常会分发90天的维持用药,并将此功能作为一项关键的成本控制策略进行营销,以解决计划发起人不断增长的处方药支出的问题。近年来,社区药房引入了90天的计划,这些计划具有类似的成本优势,同时允许将这些处方药分配给患者经常使用30天的相同药房。目的:比较在社区和邮购药房获得90天处方药的利用率和相应成本,以了解在不同90天配药渠道中具有同等收益的付款人。方法:在2008年1月至2010年9月之间,我们使用大型PBM雇主组客户的药房索赔和资格数据进行了回顾性横断面调查。我们不包括以下客户类型:政府,第三方管理员,学校,医院, 340B(联邦药品定价),波多黎各的雇主以及PBM为其提供计费服务的其他客户(例如,药房的会员卡计划会员)。样本中的所有雇主团体都提供了为期90天的社区药房和邮购单据,并从PBM获得了福利管理服务,例如配方管理和邮购药房。我们进一步将样本限制在为社区药房和邮购提供同等利益的雇主群体中,这些群体定义为这样的群体:社区和邮购药店的每项索赔的平均和自付共付额之间的差异不超过5%。样本中的参加者在每个日历年必须至少有6个月的资格,但在任何一年都不需要填写处方。我们评估了14种经常分配的维持性治疗类药物的市场价格和药房成本。邮购渠道中每个治疗类别的索赔要求的比例份额用于加权社区药房渠道的结果。使用普通最小二乘回归模型,我们针对以下混杂因素控制了渠道用户之间的差异:年龄,性别,是否存在前11种以药物为依据的疾病(例如哮喘/慢性阻塞性肺疾病,心血管疾病)疾病),药物组合和日历年。我们计算了将所有协变量保持在平均值的估计预测均值。对于这两个90天的配药渠道,我们计算了每个成员每年90天的索赔数量(PMPY)和每个药房索赔的成本,所有索赔计数均调整为30天等值(即90天的索赔数量×3 )。使用t检验比较差异,以显示统计学显着性。结果:在排除之前的355个PBM客户中,分析中涵盖了72,唯一的雇主,涵盖了644,071个唯一的成员(每个雇主大约100至100,000多个成员)。在未经调整的基础上,社区药房占90天市场购物篮索赔的80.8%(相当于30天:PMPY为3.97,而邮购为0.95)和允许的总费用的77.2%。在调整治疗组组合和患者特征后,社区药房的平均药房申领计数PMPY为4.09,而邮购为0.85(P <0.001)。社区和邮购药房的每项索赔的预计平均允许收费没有显着差异(分别为49.03美元和50.04美元,P = 0.202)。结论:当通过社区和邮购药店以等价的方式提供维持药物时,就索赔PMPY而言,商业投保的雇员及其家属更频繁地利用社区药房渠道,比例超过4:1。社区和邮购药房每项索赔的总允许费用没有明显差异

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号